Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v1-EN
Language English English
Date Updated 2021-11-18 2021-07-26
Drug Identification Number 02014211 02014211
Brand name MS.IR MS.IR
Common or Proper name Morphine Sulfate Sustained Release Tablets Morphine Sulfate Sustained Release Tablets
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients MORPHINE SULFATE MORPHINE SULFATE
Strength(s) 10MG 10MG
Dosage form(s) TABLET (IMMEDIATE RELEASE) TABLET (IMMEDIATE RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2021-07-26 2021-07-26
Actual start date 2021-07-26 2021-07-26
Estimated end date 2021-11-26 2021-08-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments